Month: September 2020

P3-OM is a transient probiotic that eliminates bad bacteria fast, eats up excess sugar and protects your gut from inflammation and viruses. It uses a patented process (patent #: 5,895,758) to dramatically enhance L. Plantarum’s abilities, resulting in a new super strain that may be the most powerful proteolytic probiotic ever developed. Inside of L
0 Comments
The world produces more than 380 million tonnes of plastic every year, and this can take up to 500 years to decompose. So is it possible to kick the habit? Happiful’s Kathryn Wheeler gave it a go Cards on the table, when sustainable online shop Let’s Go Plastic Free challenged me to give up plastic
0 Comments
New studies with topics ranging from vaping to insomnia provide important health and safety updates for consumers. Your shoes can produce muscle issues Researchers at Harvard University conducted a study to test the impact of the curve at the tip of your shoes, called a toe spring. Toe springs bend slightly upward on shoes, usually
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The coronavirus may damage blood marrow cells in patients with severe COVID-19, according to a new study published in the journal Science Immunology. Previous studies have found that COVID-19 creates an “exaggerated” response from the immune system, and for some patients,
0 Comments
Reviewed by Emily Henderson, B.Sc.Sep 22 2020 In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS). Published in the Proceedings of the National Academy of Sciences, the results of the study
0 Comments
umbralisib Treatment for Marginal Zone Lymphoma; Follicular lymphoma TG Therapeutics Announces FDA Acceptance of New Drug Application for Umbralisib as a Treatment for Patients with Previously Treated Marginal Zone Lymphoma and Follicular Lymphoma Print this page NEW YORK, Aug. 13, 2020 (GLOBE NEWSWIRE) – TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that the U.S. Food and Drug Administration (FDA) has accepted
0 Comments
News FDA Alerts FDA Alerts of Perrigo’s Voluntary Albuterol Inhaler Recall September 21, 2020 Print this page Audience: Consumer, Health Professional, Pharmacy September 21, 2020 — The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of all unexpired albuterol sulfate inhalation aerosol manufactured by Catalent Pharma Solutions
0 Comments
Pictured in this video screen grab is a volunteer receiving a Russian-made polyvalent vector vaccine for COVID-19 as part of clinical trials at Sechenov First Moscow State Medical University. Sechenov Medical University Press Office | TASS | Getty Images As the coronavirus pandemic continues to rage around the world, a lot of hope is being
0 Comments
Reviewed by Emily Henderson, B.Sc.Sep 22 2020 A new Canadian study reveals that the psychological and physical effects of childhood sexual abuse are closely tied. The finding could help healthcare professionals develop more effective interventions and ultimately improve mental and physical health outcomes for survivors of abuse in childhood. Authored by Pascale Vézina-Gagnon, a PhD
0 Comments
Accounting for the ISCHEMIA trial in appropriate use criteria (AUC) would substantially shift the proportion of coronary revascularizations considered proper. But stronger (i.e., legal) measures would speed change in practice patterns, researchers suggested. Under the current AUC classification system, 56.2% of the more than 200,000 percutaneous coronary interventions (PCIs) recorded in the national CathPCI registry
0 Comments
Colleges and universities that have required – not asked, not suggested, not tried to reason with – their students to follow safety protocols concerning the spread of coronavirus seem to have the fewest cases of COVID-19. Clear evidence of this statement is Hamilton, a liberal arts college in Clinton, NY. As of September 18, it
0 Comments
Systemic lupus erythematosus remains a treatment challenge, but a variety of drugs in the pipeline are set to target type I interferons, cytokines, and B cells, according to Richard Furie, MD, chief of the division of rheumatology at Northwell Health and professor of medicine at Hofstra University, Hempstead, N.Y. In general, when treating patients with systemic
0 Comments
Keto Desserts is the one cookbook everyone needs to have in their collection. It’s a digital cookbook infused with dessert recipes that are keto-friendly and that have eliminated the unhealthy, traditional ingredients. Yes, that includes many things but what will surprise you is that the healthier alternatives provided are just as delicious, if not more
0 Comments
Good news. Those homemade face masks work — and they might even be more breathable than medical masks, a recent study shows. The findings were published in the journal Extreme Mechanics Letters. With the supply of professional and medical face masks limited, the Centers for Disease Control and Prevention (CDC) has recommended that people make
0 Comments
Early on in the COVID-19 pandemic, clinicians intubated many patients with respiratory insufficiency because of concern for aerosolization with other methods. “We were concerned that, if we put them on high-flow nasal cannula or a noninvasive ventilation, that we would create aerosols that would then be a risk to clinicians,” Meghan Lane-Fall, MD, MSHP, FCCM, said at
0 Comments
Print this page Tokyo, Basking Ridge, N.J. and Munich – (September 14, 2020) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that the first patient has been dosed in a phase 2 study evaluating patritumab deruxtecan (U3-1402), a HER3 directed DXd antibody drug conjugate (ADC), in patients with advanced or metastatic colorectal cancer who
0 Comments
trilaciclib Treatment for Small Cell Lung Cancer G1 Therapeutics Announces Acceptance and Priority Review of NDA for Trilaciclib for Patients with Small Cell Lung Cancer Print this page RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2020 (GLOBE NEWSWIRE) – G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New
0 Comments
September 17, 2020 Print this page Audience: Consumer, Health Professional, Pharmacy September 17, 2020 — Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has found these lots
0 Comments
As trust in federal health agencies has withered over the last few months, a group of Black physicians has been working on an antidote: creating their own expert task force to independently vet regulators’ decisions about Covid-19 drugs and vaccines as well as government recommendations for curbing the pandemic. Organized by the National Medical Association — founded
0 Comments
Note that some links may require registration or subscription. IL-6 inhibitor tocilizumab (Actemra) showed a modest benefit in hospitalized COVID-19 patients, Genentech announced Friday. AstraZeneca on Saturday released its vaccine trial protocol, making it the third developer to do so amidst calls for transparency. (New York Times) As of Monday at 8:00 a.m. EDT, the
0 Comments
“What we’ve done is cause an unintended spike in stillbirth while trying to protect [pregnant women] from COVID-19.”  So says Jane Warland, a nurse-midwife and researcher at the University of South Australia, in a story for Nature, chronically a rise in stillbirths that researchers have begun to see in some parts of the world.  Results from
0 Comments
Researchers have identified five cognitive phenotypes among patients with multiple sclerosis (MS). The lead researcher described the clinical characteristics and MRI findings unique to each phenotype during a lecture at the Joint European Committee for Treatment and Research in Multiple Sclerosis–Americas Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS–ACTRIMS) 2020, this year known as
0 Comments